We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Moderate to strong immunoreactivity was observed in renal and thyroid cancers. Several cases of melanomas, endometrial, ovarian and skin cancers along with a few cases of colorectal, breast, cervical and pancreatic cancers showed weak to moderate staining. Remaining tumors were mainly negative.
Several cases of thyroid and hepatocellular carcinomas along with few cases of lung, pancreatic and renal cancers showed moderate cytoplasmic positivity. Remaining cancer tissues were in general negative.
Q9BUT1 [Direct mapping] 3-hydroxybutyrate dehydrogenase type 2 A0A024RDG9 [Target identity:100%; Query identity:100%] 3-hydroxybutyrate dehydrogenase, type 2, isoform CRA_b
Show all
Enzymes ENZYME proteins Oxidoreductases Phobius predicted secreted proteins Predicted intracellular proteins Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0003858 [3-hydroxybutyrate dehydrogenase activity] GO:0005737 [cytoplasm] GO:0005829 [cytosol] GO:0006635 [fatty acid beta-oxidation] GO:0016491 [oxidoreductase activity] GO:0016628 [oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor] GO:0019290 [siderophore biosynthetic process] GO:0030855 [epithelial cell differentiation] GO:0042168 [heme metabolic process] GO:0044255 [cellular lipid metabolic process] GO:0044281 [small molecule metabolic process] GO:0046950 [cellular ketone body metabolic process] GO:0046951 [ketone body biosynthetic process] GO:0051287 [NAD binding] GO:0055072 [iron ion homeostasis] GO:0070062 [extracellular exosome]